Javad Shahidi
Senior Vice President, Head of Biotech Unit & Development Innovation BeOne Medicines
Dr. Javad Shahidi is a physician with a long track record in oncology drug development. For more than a decade, Dr. Shahidi has been leading the clinical development of multiple biologics including Antibody Drug Conjugates across various stages from pre-IND to global regulatory approvals. He currently serves as the Senior Vice President – Head of Biotech Unit and Development Innovation at BeOne Medicines.
Seminars
- ADC development has become increasingly challenging and meaningful differentiation exceedingly difficult due to an explosion in competition
- More than ever, time- and cost-efficient development execution is essential to be able to win in this crowded landscape
- Designing a new model of a Global Development SuperHighway to create win-win partnership opportunities and solve the problem of access to high-quality and efficient development execution
Discover what drives licensing decisions, investment strategies, and M&A activity, from making your ADC programmes attractive to where the next shift in the industry is heading. As large pharma companies increasingly compete for differentiated ADC platforms and clinical-stage assets, understanding the data, innovation, and risk factors behind successful deals has never been more important.
- Discussion 1 – Building the Next Wave of ADC Drugs Through Biopharma Acquisitions & Technology Scouting
- Discussion 2 – Turbocharging Biotech Innovation & Differentiation to Achieve Successful Fund Raising Rounds